Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

4.55
Delayed Data
As of Jun 24
 -0.25 / -5.21%
Today’s Change
2.85
Today|||52-Week Range
10.81
-15.74%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.80
Today’s open4.53
Day’s range4.35 - 4.67
Volume652,666
Average volume (3 months)508,067
Market cap$136.8M
Dividend yield--
Data as of 4:14pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-21.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.20-3.81%
LNTHLantheus Holdings In...+0.06+2.22%
CALACalithera Bioscience...-0.25-5.94%
TRILTrillium Therapeutic...-0.48-4.89%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs